Autopsy of a Drug Withdrawal — The Case of Melphalan Flufenamide

A December 2022 law introduced a new expedited withdrawal process for accelerated approvals. The first approval withdrawn with this pathway was that of melphalan flufenamide.

​   The New England Journal of Medicine: Search Results in Hematology/Oncology